| 崙棫堛栻昳怘昳塹惗尋媶強 |
National Institute of Health Sciences |
| 惗暔栻昳晹 |
Division of Biological Chemistry and Biologicals |
|
丂丂丂 |
亂rINN亃iodine (124I) girentuximab (List 63, 2010, Vol.24, No. 1, p62)
亂pINN亃iodine (124I) girentuximab (List 101, 2009, Vol.23, No. 2, p152)
亂夝愢乮榓栿乯亃
IgG1內, 峈僸僩扽巁扙悈峺慺IX(TGFB, TGFbeta 枖偼 TGF-beta, TGF-儀乕僞-1 枖偼TGFB1, TGF-儀乕僞-2,
TGFB2 枖偼G-TsF, 媦傃TGF-beta-3 枖偼 TGFB3傪娷傓), 僉儊儔儌僲僋儘乕僫儖峈懱; 曻幩惈摨埵尦慺昗幆柶塽恌抐栻丏
H嵔 (兞1嵔丆1-449)丗[Mus musculus VH (IGHV5-6-2*01 -(IGHD)-IGHJ4*01) [8.8.12]
(1-119) -Homo sapiens IGHG1*01 (120-449)]丏
L嵔(內嵔丆1'-214')丗[Mus musculus V-KAPPA (IGKV6-13*01 -IGKJ1*01) [6.3.9] (1'-107')
-Homo sapiens IGKC*01 (108'-214')]丏
儓僂慺-124偑嫟桳寢崌
僕僗儖僼傿僪寢崌偺寢崌埵抲丟222-214', 228-228''丆231-231''
摐嵔晅壛埵抲丗299, 299''
C6460H(10006-n)124InN1718O2018S48
亂CAS斣崋亃1011710-99-8
亂JAN亃枹廂嵹
|
|
| Copyright (C) 丂丂丂Division of Biological Chemistry and Biologicals丂丂丂All
rights reserved. |
|
|